Trial Profile
Use of limited sampling strategy to evaluate the relationship between pharmacokinetics and farmacogenetics of the anticancer drugs Docetaxel (Taxotere) and Paclitaxel (Taxol).
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 18 May 2010
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Paclitaxel (Primary)
- Indications Cancer
- Focus Pharmacogenomic; Pharmacokinetics
- 18 May 2010 New trial record